PLEURAL MESOTHELIOMA
Clinical trials for PLEURAL MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new PLEURAL MESOTHELIOMA trials appear
Sign up with your email to follow new studies for PLEURAL MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radiation and immunotherapy join forces against mesothelioma
Disease control CompletedThis early-phase trial is testing whether combining a precise type of radiation (SBRT) with immunotherapy can safely treat pleural mesothelioma, a rare cancer of the lung lining. About 20 adults with confirmed mesothelioma will receive both treatments. The main goal is to see if …
Matched conditions: PLEURAL MESOTHELIOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Immunotherapy plus chemo shows promise in tough lung cancer
Disease control CompletedThis study tested whether adding the immunotherapy drug durvalumab to standard chemotherapy helps people with advanced pleural mesothelioma live longer. The trial included 214 adults whose cancer could not be removed by surgery. Participants received either the combination or a s…
Matched conditions: PLEURAL MESOTHELIOMA
Phase: PHASE3 • Sponsor: PrECOG, LLC. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
300 patients studied to uncover hidden causes of fluid in the lungs
Knowledge-focused CompletedThis completed study looked at 300 patients with pleural effusion—fluid buildup around the lungs—to find out what caused it. Researchers reviewed medical records to classify the fluid type and identify underlying conditions like heart failure, infection, or cancer. The goal was t…
Matched conditions: PLEURAL MESOTHELIOMA
Sponsor: Mansoura University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC